רווח נקי למניה (EPS TTM): Azitra Corp (AZTR)

The current rolling earnings per share level for Azitra, Inc. (AZTR) correlates with the implementation of robotic microbiome analysis, which accelerates testing. The value -13.06 shows the current value of the metric. The production cycle is based on outsourcing through US CMO plants. Stable management focuses on microbial dermatology and the optimization of clinical trial recruitment, maintaining investor confidence in the asset.

For the biotech startup Azitra, Inc. (AZTR), TTM net income per share serves as a marker of financial viability. This indicator measures total income distributed across the entire share issuance over the last twelve months. This calculation offsets the impact of secondary offerings, allowing for an assessment of real capitalization efficiency. In the microbiome therapy niche, steady growth of this metric confirms resilience against expansion by beauty behemoths. Negative dynamics signal risks of development devaluation upon the emergence of strong competitors.